BRAF/MEK inhibition in melanoma patients with rare BRAF mutations.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jessica Cecile Hassel, Christian Menzer, Alexander M. Menzies, Matteo S. Carlino, Georgina V. Long, Richard Kefford, Thomas K. Eigentler, Douglas Buckner Johnson, Max Schlaak, Frank Meiss, Bastian Schilling, Ralf Gutzmer, Claudia Pföhler, Friedegund Elke Meier, Lisa Zimmer, Thomas Haalck, Kai Thoms, Annette Kopp-Schneider, Alexander Enk
Institutions: Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Melanoma Institute Australia, The University of Sydney, Royal North Shore Hospital, Westmead Hospital, Macquarie University, Universitätsklinikum Tübingen, Vanderbilt University Medical Center, University Hospital Cologne, University of Freiburg, Universitätsklinikum Würzburg, Medizinische Hochschule Hannover, Universitätsklinikum des Saarlandes, University Hospital Carl Gustav Carus, Essen University Hospital, University of Duisburg-Essen, University Medical Center Hamburg-Eppendorf, Universitätsmedizin Göttingen, German Cancer Research Center
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2891602996